Recombinant CCL2 (Carlumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, WB
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all CCL2 (Carlumab Biosimilar) products
- CCL2 (Carlumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This CCL2 (Carlumab Biosimilar) antibody is un-conjugated
- Application
- ELISA, Western Blotting (WB)
- Purpose
- Carlumab Biosimilar – Anti-CCL2 mAb - Research Grade
- Characteristics
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Purity
- > 85%
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
anti-CCL2 (Carlumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- CCL2 (Carlumab Biosimilar)
- Abstract
- CCL2 (Carlumab Biosimilar) Products
- Background
- Carlumab is a human anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer.
- CAS-No
- 915404-94-3
-
You are here:
